D-lactic Acidosis: Successful Suppression of D-lactate-Producing <i>Lactobacillus</i> by Probiotics.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30089656.
- Also identified by DOI 10.1542/peds.2018-0337.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intestinal microbiota composition in children with short bowel syndrome (SBS) is an important factor influencing the clinical outcome. An increase of D-lactate-producing bacteria can lead to D-lactic acidosis, also referred to as D-lactate encephalopathy, with severe neurologic impairment. Antibiotic treatments for D-lactic acidosis in children with SBS offer often only short-term relief. Here, we present the case of a boy with SBS who developed recurrent episodes of D-lactic acidosis even under continuous cycling antibiotic treatment. Microbiological analyses were used to detect the presence of D-lactate-producing <i>Lactobacillus</i> species in the stool samples. A probiotic cocktail was introduced to alter the intestinal microbiota. During follow-up under treatment with probiotics, the patient remained stable, and there was no additional need for antibiotic therapy for more than a year. Stool composition of the patient was sequenced regularly over that period. His microbiota profile changed completely in species richness, and a clustering of species according to probiotic usage was seen. Importantly, D-lactate-producing <i>Lactobacillus</i> strains disappeared within a few weeks after probiotic introduction and were no longer detected in the subsequent follow-up specimens.
Medical subject headings
- Acidosis, Lactic
- Gastrointestinal Microbiome
- Lactobacillus
- Probiotics
- Short Bowel Syndrome